Sunao Manabe takes top job at Daiichi Sankyo in wake of AstraZeneca deal; CAR-T player Celyad promotes Filippo Petti to CEO
→ Barely a day after Daiichi Sankyo wrapped a mammoth collaboration deal with AstraZeneca, the Japanese pharma announced a succession plan for its CEO. George Nakayama, who’s keeping his chairman seat, is passing the reins to Sunao Manabe, currently president and COO. This marks one of the final transitions as Nakayama winds down his decades-long career run with the company, starting at Daiichi subsidiary Suntory in 1979. He delegated the president role two years ago.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.